1. Home
  2. QLGN vs DGLY Comparison

QLGN vs DGLY Comparison

Compare QLGN & DGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • DGLY
  • Stock Information
  • Founded
  • QLGN 1996
  • DGLY 2004
  • Country
  • QLGN United States
  • DGLY United States
  • Employees
  • QLGN N/A
  • DGLY N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • QLGN Health Care
  • DGLY Technology
  • Exchange
  • QLGN Nasdaq
  • DGLY Nasdaq
  • Market Cap
  • QLGN 2.2M
  • DGLY 2.4M
  • IPO Year
  • QLGN N/A
  • DGLY N/A
  • Fundamental
  • Price
  • QLGN $3.48
  • DGLY $0.03
  • Analyst Decision
  • QLGN
  • DGLY
  • Analyst Count
  • QLGN 0
  • DGLY 0
  • Target Price
  • QLGN N/A
  • DGLY N/A
  • AVG Volume (30 Days)
  • QLGN 158.4K
  • DGLY 94.7M
  • Earning Date
  • QLGN 05-06-2025
  • DGLY 05-16-2025
  • Dividend Yield
  • QLGN N/A
  • DGLY N/A
  • EPS Growth
  • QLGN N/A
  • DGLY N/A
  • EPS
  • QLGN N/A
  • DGLY N/A
  • Revenue
  • QLGN N/A
  • DGLY $21,131,122.00
  • Revenue This Year
  • QLGN N/A
  • DGLY $22.14
  • Revenue Next Year
  • QLGN N/A
  • DGLY N/A
  • P/E Ratio
  • QLGN N/A
  • DGLY N/A
  • Revenue Growth
  • QLGN N/A
  • DGLY N/A
  • 52 Week Low
  • QLGN $2.85
  • DGLY $0.02
  • 52 Week High
  • QLGN $29.45
  • DGLY $3.29
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 52.85
  • DGLY 30.34
  • Support Level
  • QLGN $3.10
  • DGLY $0.02
  • Resistance Level
  • QLGN $4.40
  • DGLY $0.08
  • Average True Range (ATR)
  • QLGN 0.40
  • DGLY 0.00
  • MACD
  • QLGN 0.05
  • DGLY 0.00
  • Stochastic Oscillator
  • QLGN 40.32
  • DGLY 40.50

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

Share on Social Networks: